nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0674	0.108	CbGbCtD
Rifabutin—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0633	0.102	CbGbCtD
Rifabutin—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0633	0.102	CbGbCtD
Rifabutin—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0573	0.092	CbGbCtD
Rifabutin—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.048	0.0771	CbGbCtD
Rifabutin—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0434	0.0697	CbGbCtD
Rifabutin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0353	0.0567	CbGbCtD
Rifabutin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0332	0.0533	CbGbCtD
Rifabutin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0332	0.0533	CbGbCtD
Rifabutin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.03	0.0482	CbGbCtD
Rifabutin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.03	0.0482	CbGbCtD
Rifabutin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0259	0.0416	CbGbCtD
Rifabutin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0252	0.0404	CbGbCtD
Rifabutin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0227	0.0365	CbGbCtD
Rifabutin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0227	0.0365	CbGbCtD
Rifabutin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0218	0.035	CbGbCtD
Rifabutin—HSP90B1—blood plasma—acquired immunodeficiency syndrome	0.00882	0.0881	CbGeAlD
Rifabutin—HSP90AA1—endothelium—acquired immunodeficiency syndrome	0.00726	0.0725	CbGeAlD
Rifabutin—HSP90AA1—blood plasma—acquired immunodeficiency syndrome	0.00645	0.0644	CbGeAlD
Rifabutin—HSP90B1—retina—acquired immunodeficiency syndrome	0.00483	0.0482	CbGeAlD
Rifabutin—HSP90B1—skin of body—acquired immunodeficiency syndrome	0.00424	0.0423	CbGeAlD
Rifabutin—HSP90AA1—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.00413	1	CbGdCrCtD
Rifabutin—HSP90AA1—retina—acquired immunodeficiency syndrome	0.00353	0.0353	CbGeAlD
Rifabutin—HSP90B1—lymphoid tissue—acquired immunodeficiency syndrome	0.00343	0.0343	CbGeAlD
Rifabutin—HSP90B1—digestive system—acquired immunodeficiency syndrome	0.00339	0.0339	CbGeAlD
Rifabutin—HSP90B1—blood—acquired immunodeficiency syndrome	0.00323	0.0323	CbGeAlD
Rifabutin—HSP90B1—bone marrow—acquired immunodeficiency syndrome	0.00312	0.0312	CbGeAlD
Rifabutin—HSP90B1—spinal cord—acquired immunodeficiency syndrome	0.00311	0.0311	CbGeAlD
Rifabutin—HSP90AA1—skin of body—acquired immunodeficiency syndrome	0.0031	0.031	CbGeAlD
Rifabutin—HSP90B1—vagina—acquired immunodeficiency syndrome	0.00299	0.0299	CbGeAlD
Rifabutin—HSP90B1—lung—acquired immunodeficiency syndrome	0.00283	0.0283	CbGeAlD
Rifabutin—HSP90B1—nervous system—acquired immunodeficiency syndrome	0.00262	0.0262	CbGeAlD
Rifabutin—HSP90B1—central nervous system—acquired immunodeficiency syndrome	0.00252	0.0252	CbGeAlD
Rifabutin—HSP90AA1—lymphoid tissue—acquired immunodeficiency syndrome	0.00251	0.0251	CbGeAlD
Rifabutin—HSP90AA1—digestive system—acquired immunodeficiency syndrome	0.00248	0.0248	CbGeAlD
Rifabutin—HSP90AA1—blood—acquired immunodeficiency syndrome	0.00236	0.0236	CbGeAlD
Rifabutin—HSP90AA1—bone marrow—acquired immunodeficiency syndrome	0.00229	0.0228	CbGeAlD
Rifabutin—HSP90AA1—spinal cord—acquired immunodeficiency syndrome	0.00228	0.0227	CbGeAlD
Rifabutin—HSP90AA1—vagina—acquired immunodeficiency syndrome	0.00219	0.0219	CbGeAlD
Rifabutin—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00208	0.0208	CbGeAlD
Rifabutin—HSP90AA1—lung—acquired immunodeficiency syndrome	0.00207	0.0207	CbGeAlD
Rifabutin—HSP90B1—brain—acquired immunodeficiency syndrome	0.002	0.02	CbGeAlD
Rifabutin—HSP90B1—lymph node—acquired immunodeficiency syndrome	0.00194	0.0193	CbGeAlD
Rifabutin—HSP90AA1—nervous system—acquired immunodeficiency syndrome	0.00192	0.0192	CbGeAlD
Rifabutin—HSP90AA1—central nervous system—acquired immunodeficiency syndrome	0.00185	0.0184	CbGeAlD
Rifabutin—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00151	0.0151	CbGeAlD
Rifabutin—HSP90AA1—brain—acquired immunodeficiency syndrome	0.00147	0.0146	CbGeAlD
Rifabutin—HSP90AA1—lymph node—acquired immunodeficiency syndrome	0.00142	0.0141	CbGeAlD
Rifabutin—HSP90AA1—Regulation of actin dynamics for phagocytic cup formation—ACTG1—acquired immunodeficiency syndrome	0.00131	0.0575	CbGpPWpGaD
Rifabutin—HSP90B1—Binding and Uptake of Ligands by Scavenger Receptors—ALB—acquired immunodeficiency syndrome	0.00129	0.0567	CbGpPWpGaD
Rifabutin—HSP90AA1—EBV LMP1 signaling—CCL5—acquired immunodeficiency syndrome	0.00125	0.0548	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.00116	0.0507	CbGpPWpGaD
Rifabutin—HSP90AA1—Fcgamma receptor (FCGR) dependent phagocytosis—ACTG1—acquired immunodeficiency syndrome	0.00099	0.0434	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—ACTG1—acquired immunodeficiency syndrome	0.000879	0.0385	CbGpPWpGaD
Rifabutin—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000801	0.00801	CbGeAlD
Rifabutin—CYP1A2—blood—acquired immunodeficiency syndrome	0.000763	0.00763	CbGeAlD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000689	0.0302	CbGpPWpGaD
Rifabutin—CYP1A2—lung—acquired immunodeficiency syndrome	0.000669	0.00669	CbGeAlD
Rifabutin—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.00058	0.0058	CbGeAlD
Rifabutin—HSP90B1—IL6-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000553	0.0242	CbGpPWpGaD
Rifabutin—CYP3A4—blood—acquired immunodeficiency syndrome	0.000553	0.00552	CbGeAlD
Rifabutin—HSP90B1—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000527	0.0231	CbGpPWpGaD
Rifabutin—HSP90AA1—Binding and Uptake of Ligands by Scavenger Receptors—ALB—acquired immunodeficiency syndrome	0.000505	0.0221	CbGpPWpGaD
Rifabutin—HSP90AA1—EBV LMP1 signaling—TNF—acquired immunodeficiency syndrome	0.000474	0.0208	CbGpPWpGaD
Rifabutin—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000449	0.00448	CbGeAlD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—CSF2—acquired immunodeficiency syndrome	0.000445	0.0195	CbGpPWpGaD
Rifabutin—HSP90AA1—IL2 signaling events mediated by PI3K—IL2—acquired immunodeficiency syndrome	0.000445	0.0195	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IL4—acquired immunodeficiency syndrome	0.000438	0.0192	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000433	0.019	CbGpPWpGaD
Rifabutin—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000432	0.00432	CbGeAlD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.00042	0.0184	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000374	0.0164	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.00034	0.0149	CbGpPWpGaD
Rifabutin—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000328	0.00131	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000328	0.00131	CcSEcCtD
Rifabutin—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000327	0.00131	CcSEcCtD
Rifabutin—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000327	0.00131	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000327	0.0143	CbGpPWpGaD
Rifabutin—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000327	0.00131	CcSEcCtD
Rifabutin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000326	0.0013	CcSEcCtD
Rifabutin—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000325	0.0013	CcSEcCtD
Rifabutin—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000325	0.0013	CcSEcCtD
Rifabutin—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000325	0.0013	CcSEcCtD
Rifabutin—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000323	0.00129	CcSEcCtD
Rifabutin—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000323	0.00129	CcSEcCtD
Rifabutin—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000322	0.00129	CcSEcCtD
Rifabutin—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000322	0.00129	CcSEcCtD
Rifabutin—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000321	0.00128	CcSEcCtD
Rifabutin—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000319	0.00127	CcSEcCtD
Rifabutin—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000319	0.00127	CcSEcCtD
Rifabutin—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000317	0.00127	CcSEcCtD
Rifabutin—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000317	0.00127	CcSEcCtD
Rifabutin—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000316	0.00126	CcSEcCtD
Rifabutin—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000316	0.00126	CcSEcCtD
Rifabutin—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000316	0.00126	CcSEcCtD
Rifabutin—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000316	0.00126	CcSEcCtD
Rifabutin—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000313	0.00125	CcSEcCtD
Rifabutin—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000311	0.00124	CcSEcCtD
Rifabutin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000311	0.00124	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000311	0.00124	CcSEcCtD
Rifabutin—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.00031	0.00124	CcSEcCtD
Rifabutin—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00031	0.00124	CcSEcCtD
Rifabutin—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000308	0.00123	CcSEcCtD
Rifabutin—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000308	0.00123	CcSEcCtD
Rifabutin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000308	0.00123	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—IFNG—acquired immunodeficiency syndrome	0.000308	0.0135	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000307	0.0135	CbGpPWpGaD
Rifabutin—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000307	0.00123	CcSEcCtD
Rifabutin—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000307	0.00123	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000306	0.0134	CbGpPWpGaD
Rifabutin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000306	0.00122	CcSEcCtD
Rifabutin—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000305	0.00122	CcSEcCtD
Rifabutin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000305	0.00122	CcSEcCtD
Rifabutin—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000305	0.00122	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000305	0.00122	CcSEcCtD
Rifabutin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000303	0.00121	CcSEcCtD
Rifabutin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000303	0.00121	CcSEcCtD
Rifabutin—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000303	0.00121	CcSEcCtD
Rifabutin—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000301	0.0012	CcSEcCtD
Rifabutin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000301	0.0012	CcSEcCtD
Rifabutin—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.0003	0.0012	CcSEcCtD
Rifabutin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.0003	0.0012	CcSEcCtD
Rifabutin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.0003	0.0012	CcSEcCtD
Rifabutin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000299	0.00119	CcSEcCtD
Rifabutin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000298	0.00119	CcSEcCtD
Rifabutin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000298	0.00119	CcSEcCtD
Rifabutin—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000298	0.00119	CcSEcCtD
Rifabutin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000297	0.00119	CcSEcCtD
Rifabutin—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000297	0.00119	CcSEcCtD
Rifabutin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000297	0.00119	CcSEcCtD
Rifabutin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000296	0.00118	CcSEcCtD
Rifabutin—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000295	0.00118	CcSEcCtD
Rifabutin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000295	0.00118	CcSEcCtD
Rifabutin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000294	0.00118	CcSEcCtD
Rifabutin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000294	0.00117	CcSEcCtD
Rifabutin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000294	0.00117	CcSEcCtD
Rifabutin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000293	0.00117	CcSEcCtD
Rifabutin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000293	0.00117	CcSEcCtD
Rifabutin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000293	0.00117	CcSEcCtD
Rifabutin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000292	0.00117	CcSEcCtD
Rifabutin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000292	0.00117	CcSEcCtD
Rifabutin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000292	0.00117	CcSEcCtD
Rifabutin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000291	0.00116	CcSEcCtD
Rifabutin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000291	0.00116	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.00116	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000289	0.00115	CcSEcCtD
Rifabutin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000289	0.00115	CcSEcCtD
Rifabutin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000288	0.00115	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000288	0.00115	CcSEcCtD
Rifabutin—Pain—Indinavir—acquired immunodeficiency syndrome	0.000286	0.00114	CcSEcCtD
Rifabutin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000286	0.00114	CcSEcCtD
Rifabutin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000286	0.00114	CcSEcCtD
Rifabutin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000284	0.00114	CcSEcCtD
Rifabutin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000284	0.00114	CcSEcCtD
Rifabutin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000284	0.00114	CcSEcCtD
Rifabutin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000284	0.00113	CcSEcCtD
Rifabutin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000283	0.00113	CcSEcCtD
Rifabutin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000283	0.00113	CcSEcCtD
Rifabutin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000282	0.00113	CcSEcCtD
Rifabutin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000282	0.00113	CcSEcCtD
Rifabutin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000282	0.00113	CcSEcCtD
Rifabutin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000281	0.00112	CcSEcCtD
Rifabutin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000281	0.00112	CcSEcCtD
Rifabutin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000281	0.00112	CcSEcCtD
Rifabutin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000279	0.00112	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.00111	CcSEcCtD
Rifabutin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000278	0.00111	CcSEcCtD
Rifabutin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000276	0.0011	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000276	0.0011	CcSEcCtD
Rifabutin—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000275	0.0011	CcSEcCtD
Rifabutin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000275	0.0011	CcSEcCtD
Rifabutin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000274	0.00109	CcSEcCtD
Rifabutin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000274	0.00109	CcSEcCtD
Rifabutin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000274	0.00109	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—IL2—acquired immunodeficiency syndrome	0.000273	0.012	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.00109	CcSEcCtD
Rifabutin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000273	0.00109	CcSEcCtD
Rifabutin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000273	0.00109	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	0.000272	0.0119	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	0.000272	0.0119	CbGpPWpGaD
Rifabutin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000272	0.00109	CcSEcCtD
Rifabutin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000272	0.00109	CcSEcCtD
Rifabutin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.00109	CcSEcCtD
Rifabutin—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00027	0.00108	CcSEcCtD
Rifabutin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00027	0.00108	CcSEcCtD
Rifabutin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00027	0.00108	CcSEcCtD
Rifabutin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.00108	CcSEcCtD
Rifabutin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000269	0.00107	CcSEcCtD
Rifabutin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000268	0.00107	CcSEcCtD
Rifabutin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000268	0.00107	CcSEcCtD
Rifabutin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000268	0.00107	CcSEcCtD
Rifabutin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.00107	CcSEcCtD
Rifabutin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000266	0.00106	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.00106	CcSEcCtD
Rifabutin—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000265	0.00106	CcSEcCtD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IFNG—acquired immunodeficiency syndrome	0.000265	0.0116	CbGpPWpGaD
Rifabutin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000265	0.00106	CcSEcCtD
Rifabutin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000265	0.00106	CcSEcCtD
Rifabutin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000264	0.00106	CcSEcCtD
Rifabutin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000264	0.00105	CcSEcCtD
Rifabutin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000263	0.00105	CcSEcCtD
Rifabutin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000263	0.00105	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000262	0.0115	CbGpPWpGaD
Rifabutin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000262	0.00105	CcSEcCtD
Rifabutin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000262	0.00105	CcSEcCtD
Rifabutin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.00105	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.00104	CcSEcCtD
Rifabutin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000261	0.00104	CcSEcCtD
Rifabutin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000261	0.00104	CcSEcCtD
Rifabutin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000261	0.00104	CcSEcCtD
Rifabutin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00026	0.00104	CcSEcCtD
Rifabutin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000259	0.00104	CcSEcCtD
Rifabutin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000259	0.00104	CcSEcCtD
Rifabutin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.00104	CcSEcCtD
Rifabutin—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.00103	CcSEcCtD
Rifabutin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000259	0.00103	CcSEcCtD
Rifabutin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000258	0.00103	CcSEcCtD
Rifabutin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000257	0.00103	CcSEcCtD
Rifabutin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000257	0.00103	CcSEcCtD
Rifabutin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.00103	CcSEcCtD
Rifabutin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000255	0.00102	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.00102	CcSEcCtD
Rifabutin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000255	0.00102	CcSEcCtD
Rifabutin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000255	0.00102	CcSEcCtD
Rifabutin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.00101	CcSEcCtD
Rifabutin—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000253	0.00101	CcSEcCtD
Rifabutin—HSP90B1—Immune System—MBL2—acquired immunodeficiency syndrome	0.000252	0.0111	CbGpPWpGaD
Rifabutin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000251	0.00101	CcSEcCtD
Rifabutin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000251	0.001	CcSEcCtD
Rifabutin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00025	0.000999	CcSEcCtD
Rifabutin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00025	0.000999	CcSEcCtD
Rifabutin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000249	0.000997	CcSEcCtD
Rifabutin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.000997	CcSEcCtD
Rifabutin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.000996	CcSEcCtD
Rifabutin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.000989	CcSEcCtD
Rifabutin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000247	0.000986	CcSEcCtD
Rifabutin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000247	0.000985	CcSEcCtD
Rifabutin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000246	0.000984	CcSEcCtD
Rifabutin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000246	0.000984	CcSEcCtD
Rifabutin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000246	0.000983	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.00098	CcSEcCtD
Rifabutin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.000979	CcSEcCtD
Rifabutin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.000973	CcSEcCtD
Rifabutin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.000972	CcSEcCtD
Rifabutin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000242	0.000968	CcSEcCtD
Rifabutin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.000966	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.000965	CcSEcCtD
Rifabutin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00024	0.00096	CcSEcCtD
Rifabutin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.000959	CcSEcCtD
Rifabutin—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.000956	CcSEcCtD
Rifabutin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.000956	CcSEcCtD
Rifabutin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.000956	CcSEcCtD
Rifabutin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.000947	CcSEcCtD
Rifabutin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000237	0.000946	CcSEcCtD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	0.000235	0.0103	CbGpPWpGaD
Rifabutin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.000935	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.000935	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000233	0.0102	CbGpPWpGaD
Rifabutin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000233	0.000931	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.000929	CcSEcCtD
Rifabutin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000929	CcSEcCtD
Rifabutin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.000922	CcSEcCtD
Rifabutin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.000921	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.00023	0.0101	CbGpPWpGaD
Rifabutin—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.00092	CcSEcCtD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	0.00023	0.0101	CbGpPWpGaD
Rifabutin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.000915	CcSEcCtD
Rifabutin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000229	0.000915	CcSEcCtD
Rifabutin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000229	0.000914	CcSEcCtD
Rifabutin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.000914	CcSEcCtD
Rifabutin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000227	0.000907	CcSEcCtD
Rifabutin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.000907	CcSEcCtD
Rifabutin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000227	0.000906	CcSEcCtD
Rifabutin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.000904	CcSEcCtD
Rifabutin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000225	0.000901	CcSEcCtD
Rifabutin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.000894	CcSEcCtD
Rifabutin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.000892	CcSEcCtD
Rifabutin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.000891	CcSEcCtD
Rifabutin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000887	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.000886	CcSEcCtD
Rifabutin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.000884	CcSEcCtD
Rifabutin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.000884	CcSEcCtD
Rifabutin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.00088	CcSEcCtD
Rifabutin—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000878	CcSEcCtD
Rifabutin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.000867	CcSEcCtD
Rifabutin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000216	0.000865	CcSEcCtD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	0.000215	0.00941	CbGpPWpGaD
Rifabutin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.000855	CcSEcCtD
Rifabutin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000214	0.000854	CcSEcCtD
Rifabutin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000851	CcSEcCtD
Rifabutin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000851	CcSEcCtD
Rifabutin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000213	0.00085	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000212	0.00928	CbGpPWpGaD
Rifabutin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000846	CcSEcCtD
Rifabutin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000843	CcSEcCtD
Rifabutin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000843	CcSEcCtD
Rifabutin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.000839	CcSEcCtD
Rifabutin—Headache—Indinavir—acquired immunodeficiency syndrome	0.00021	0.000838	CcSEcCtD
Rifabutin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.000827	CcSEcCtD
Rifabutin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.000824	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000206	0.00903	CbGpPWpGaD
Rifabutin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.000812	CcSEcCtD
Rifabutin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.000812	CcSEcCtD
Rifabutin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.000803	CcSEcCtD
Rifabutin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000802	CcSEcCtD
Rifabutin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.000797	CcSEcCtD
Rifabutin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.000796	CcSEcCtD
Rifabutin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000199	0.000794	CcSEcCtD
Rifabutin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000793	CcSEcCtD
Rifabutin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.000792	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CCR2—acquired immunodeficiency syndrome	0.000198	0.00868	CbGpPWpGaD
Rifabutin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000791	CcSEcCtD
Rifabutin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000772	CcSEcCtD
Rifabutin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.000769	CcSEcCtD
Rifabutin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.000765	CcSEcCtD
Rifabutin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000762	CcSEcCtD
Rifabutin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000762	CcSEcCtD
Rifabutin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000761	CcSEcCtD
Rifabutin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.000757	CcSEcCtD
Rifabutin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000756	CcSEcCtD
Rifabutin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.000751	CcSEcCtD
Rifabutin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000737	CcSEcCtD
Rifabutin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.000736	CcSEcCtD
Rifabutin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000726	CcSEcCtD
Rifabutin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.000718	CcSEcCtD
Rifabutin—HSP90B1—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000178	0.00781	CbGpPWpGaD
Rifabutin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000711	CcSEcCtD
Rifabutin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000705	CcSEcCtD
Rifabutin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000704	CcSEcCtD
Rifabutin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000702	CcSEcCtD
Rifabutin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.0007	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CD79A—acquired immunodeficiency syndrome	0.000173	0.00758	CbGpPWpGaD
Rifabutin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000684	CcSEcCtD
Rifabutin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000679	CcSEcCtD
Rifabutin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000678	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000169	0.00742	CbGpPWpGaD
Rifabutin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000674	CcSEcCtD
Rifabutin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000664	CcSEcCtD
Rifabutin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000653	CcSEcCtD
Rifabutin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000647	CcSEcCtD
Rifabutin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000647	CcSEcCtD
Rifabutin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000643	CcSEcCtD
Rifabutin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000639	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000157	0.0069	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000156	0.00685	CbGpPWpGaD
Rifabutin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.00061	CcSEcCtD
Rifabutin—HSP90AA1—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.00015	0.00658	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000148	0.00647	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000141	0.00618	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CD8A—acquired immunodeficiency syndrome	0.000139	0.00611	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CSF2—acquired immunodeficiency syndrome	0.000139	0.00611	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	0.000138	0.00606	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000138	0.00603	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000134	0.00588	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000134	0.00586	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000133	0.00582	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CCNT1—acquired immunodeficiency syndrome	0.000128	0.0056	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000126	0.00553	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ACTG1—acquired immunodeficiency syndrome	0.00012	0.00526	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000119	0.00524	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	0.000112	0.0049	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	0.000106	0.00463	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MBL2—acquired immunodeficiency syndrome	9.86e-05	0.00432	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	8.99e-05	0.00394	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	8.94e-05	0.00392	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	8.94e-05	0.00392	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	8.84e-05	0.00388	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IFNG—acquired immunodeficiency syndrome	8.29e-05	0.00364	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	8.09e-05	0.00354	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CD4—acquired immunodeficiency syndrome	8.01e-05	0.00351	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	7.98e-05	0.0035	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	7.86e-05	0.00344	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CCR2—acquired immunodeficiency syndrome	7.73e-05	0.00339	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—IL6—acquired immunodeficiency syndrome	7.44e-05	0.00326	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL2—acquired immunodeficiency syndrome	7.37e-05	0.00323	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	7.34e-05	0.00322	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNA1—acquired immunodeficiency syndrome	6.96e-05	0.00305	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD79A—acquired immunodeficiency syndrome	6.75e-05	0.00296	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CXCR4—acquired immunodeficiency syndrome	6.71e-05	0.00294	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	6.32e-05	0.00277	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	5.72e-05	0.00251	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	5.72e-05	0.00251	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.52e-05	0.00242	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD40LG—acquired immunodeficiency syndrome	5.51e-05	0.00241	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CSF2—acquired immunodeficiency syndrome	5.44e-05	0.00239	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD8A—acquired immunodeficiency syndrome	5.44e-05	0.00239	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	5.43e-05	0.00238	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CD4—acquired immunodeficiency syndrome	5.37e-05	0.00235	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-B—acquired immunodeficiency syndrome	5.24e-05	0.0023	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5e-05	0.00219	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.7e-05	0.00206	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.7e-05	0.00206	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—IL6—acquired immunodeficiency syndrome	4.61e-05	0.00202	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CCR5—acquired immunodeficiency syndrome	4.6e-05	0.00202	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL6—acquired immunodeficiency syndrome	4.33e-05	0.0019	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TNF—acquired immunodeficiency syndrome	4.07e-05	0.00179	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.57e-05	0.00157	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.52e-05	0.00154	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	3.31e-05	0.00145	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—IL6—acquired immunodeficiency syndrome	3.29e-05	0.00144	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNG—acquired immunodeficiency syndrome	3.24e-05	0.00142	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.22e-05	0.00141	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD4—acquired immunodeficiency syndrome	3.13e-05	0.00137	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6—acquired immunodeficiency syndrome	2.9e-05	0.00127	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CD4—acquired immunodeficiency syndrome	2.89e-05	0.00127	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL2—acquired immunodeficiency syndrome	2.88e-05	0.00126	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.81e-05	0.00123	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ALB—acquired immunodeficiency syndrome	2.74e-05	0.0012	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.55e-05	0.00112	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	2.17e-05	0.000952	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.86e-05	0.000815	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6—acquired immunodeficiency syndrome	1.69e-05	0.000741	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6—acquired immunodeficiency syndrome	1.56e-05	0.000684	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.3e-05	0.000568	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.09e-05	0.000479	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.77e-06	0.000253	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	4.45e-06	0.000195	CbGpPWpGaD
